2009 | 20대 이하 간세포암종의 증례 : 20세 미만의 젊은 연령에서 발병한 간세포암종 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
2010 | Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. | CELL TRANSPLANTATION |
2010 | Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study | MAGNETIC RESONANCE IMAGING |
1999 | Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
2012 | Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
2009 | Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
2005 | Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma | LIVER INTERNATIONAL |
2006 | Long-term Clinical Outcome of Phase IIb Clinical Trial of Percutaneous Injection with Holmium-166/Chitosan Complex (Milican) for the Treatment of Small Hepatocellular Carcinoma
| CLINICAL CANCER RESEARCH |
2013 | Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization
| CLINICAL CANCER RESEARCH |
2008 | Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
| CANCER |
2008 | Prediction of microvascular invasion before curative resection of hepatocellular carcinoma | JOURNAL OF SURGICAL ONCOLOGY |
2013 | Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
| BMC CANCER |
2013 | Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation | EUROPEAN JOURNAL OF CANCER |
2012 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
2004 | Treatment Outcome of Transcatheter Arterial Chemoinfusion According to Anticancer Agents and Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma (TNM Stage IVa)
| YONSEI MEDICAL JOURNAL |
2007 | Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B | HEPATOLOGY |
2005 | 간문맥종양혈전증을 동반한 간세포암종에서 반복적인 간동맥 내 항암약물주입요법의 효과
| Korean Journal of Hepatology (대한간학회지) |
2005 | 간세포암 환자에서 간동맥 화학색전술 후 발생한 급성 간부전의 위험인자
| Korean Journal of Medicine (대한내과학회지) |
2009 | 간암에서 좋은 결과를 예상하고 치료를(TACE, RFA, OP/LT, Cyber knife 등) 하였으나 조기 재발한 간암 증례 : 좋은 결과를 예상하고 수술을 하였으나 조기 재발한 간세포암종 1예
| Journal of the Korean Liver Cancer Study Group (대한간암연구회지) |
2007 | 이차성 비기능항진증에서 부분적 비장동맥색전술의 장기 치료 효과
| Korean Journal of Medicine |